Advanced visualizations to interpret prescription drug monitoring program information

Drug and Alcohol Dependence - Tập 201 - Trang 260-265 - 2019
Scott G. Weiner1, Karen M. Sherritt2, Zoe Tseng3, Jaya Tripathi4
1Department of Emergency Medicine, Brigham and Women’s Hospital, 75 Francis Street, NH-226, Boston, MA 02115, United States
2Department of Medicine, The Phyllis Jen Center for Primary Care, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, United States
3Department of Medicine, Brigham and Women’s Hospital, 272 Centre Street, Newton, MA 02458, United States
4MITRE Corporation, 202 Burlington Road, Bedford, MA 01730, United States

Tài liệu tham khảo

Appriss Health, 2019 Becker, 2017, Multiple sources of prescription payment and risky opioid therapy among veterans, Med. Care, 55, S33, 10.1097/MLR.0000000000000722 Centers for Disease Control and Prevention (CDC), 2019 Deyo, 2014, Leading a horse to water: facilitating registration and use of a prescription drug monitoring program, Clin. J. Pain, 31, 782, 10.1097/AJP.0000000000000180 Fink, 2018, Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review, Ann. Intern. Med., 168, 783, 10.7326/M17-3074 Grecu, 2019, Mandatory access prescription drug monitoring programs and prescription drug abuse, J. Policy Anal. Manage., 38, 181, 10.1002/pam.22098 Haffajee, 2015, Mandatory use of prescription drug monitoring programs, JAMA, 313, 891, 10.1001/jama.2014.18514 Haffajee, 2018, Four states with robust prescription drug monitoring programs reduced opioid dosages, Health Aff. (Millwood), 37, 964, 10.1377/hlthaff.2017.1321 Hoppe, 2015, Emergency physician interpretation of prescription drug monitoring program profiles, Acad. Emerg. Med., 22, S16 Huizenga Irvine, 2014, Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians, J. Pain, 15, 747, 10.1016/j.jpain.2014.04.003 IQVIA Institute for Human Data Science Larochelle, 2016, Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study, Ann. Intern. Med., 164, 1, 10.7326/M15-0038 Leichtling, 2019, Physician responses to enhanced prescription drug monitoring program profiles, Pain Med. Manasco, 2016, Characteristics of state prescription drug monitoring programs: a state-by-state survey, Pharmacoepidemiol. Drug Saf., 25, 847, 10.1002/pds.4003 Poon, 2016, Usability of the Massachusetts prescription drug monitoring program in the emergency department: a mixed-methods study, Acad. Emerg. Med., 23, 406, 10.1111/acem.12905 Rasubala, 2015, Impact of a mandatory prescription drug monitoring program on prescription of opioid analgesics by dentists, PLoS One, 10, 10.1371/journal.pone.0135957 Rutkow, 2015, Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access, Health Aff. (Millwood), 34, 484, 10.1377/hlthaff.2014.1085 Sacco Seth, 2018, Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016, MMWR Morb. Mortal. Wkly. Rep., 30, 349, 10.15585/mmwr.mm6712a1 Shearer, 2000, The CRISP-DM model: the new blueprint for data mining, J. Data Warehouse, 5, 13 Shev, 2018, Prescription drug monitoring program: registration and use by prescribers and pharmacists before and after legal mandatory registration, California, 2010-2017, Am. J. Public Health, 108, 1669, 10.2105/AJPH.2018.304704 Suffoletto, 2018, The effect of a statewide mandatory prescription drug monitoring program on opioid prescribing by emergency medicine providers across 15 hospitals in a single health system, J. Pain, 19, 430, 10.1016/j.jpain.2017.11.010 Sun, 2018, Variations in prescription drug monitoring program use by prescriber specialty, J. Subst. Abuse Treat., 94, 35, 10.1016/j.jsat.2018.08.006 Tripathi Williams, 2018, Prescription drug monitoring programs: relationships among program awareness, use, and state mandates, J. Pain Palliat. Care Pharmacother., 10, 1 Winstanley, 2018, Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing, Drug Alcohol Depend., 188, 169, 10.1016/j.drugalcdep.2018.03.036 Wisconsin.gov